Abstract：ObjectiveTo investigate the effect of pharmaceutical intervention on the use of Alanyl-glutamine in patients with tumor.MethodsFrom 2016 to 2017,a total of 904 patients with tumor were treated with Alanyl-glutamine in our hospital were selected as the research objects.662 cases of hospitalized patients with tumor in 2016 were selected as before intervention group,242 patients with inpatient tumors treated with Alanyl-glutamine were treated as after intervention group in the course of the pharmaceutical intervention in 2017.The case data before and after the intervention were collected,and the rationality of the clinical use of Alanyl-glutamine before and after the intervention were compared.ResultsAfter intervention,the average treatment course of Alanyl-glutamine in patients with tumor was shorter than before intervention,and the difference was statistically significant(P＜0.01).After intervention,the rate of unreasonable drug use was significantly less than before intervention,and the difference was statistically significant(P＜0.01).After intervention,the unadjusted rate of medication beyond the indication,preparation of high-concentration medication and overlong course of medication treatment after the intervention were lower than before the intervention,and the differences were statistically significant(P＜0.01).ConclusionApplication of pharmaceutical intervention in the use of Alanyl-glutamine in patients with tumor makes the clinical medication standard and reasonable,indicating that pharmaceutical intervention is feasible and effective.
林燕;吴坤生;邱永军;祝敏芳;李克. 药学干预对肿瘤患者丙氨酰谷氨酰胺使用的效果分析[J]. 中国当代医药, 2017, 24(30): 79-82.
LIN Yan;WU Kun-sheng;QIU Yong-jun;ZHU Min-fang;LI Ke. Analysis of effect of pharmaceutical intervention on the use of Alanyl-glutamine in patients with tumor. 中国当代医药, 2017, 24(30): 79-82.
Baldi S，Aquilani R，Pinna GD，et al.Fat-free mass change after mutritional rehabilitation in weight losing COPD：role of insulin，Creactive protein and tissue hypoxia[J].Int J Chron Obstruct Pulmon Dis，2010，18（5）：29-39.
McClave SA，Martindale RG，Vanek VW，et al.Guidelines for the provision and assessment of nutrition support therapy in the adult critically Ⅲ patient：Society of Critical Care Medicine （SCCM）and American Society for Parenteral and Enteral Nutrition （ASPEN）[J].JPEN J Parenter Enteral Nutr，2009，33（3）：277-316.
京公网安备 11010502046607号